Sample | Title | Value | Rank |
GSM780707 | Untreated after 4 days (C1_1) | 45.2292 | 28 |
GSM780708 | Untreated after 4 days (C2_1) | 39.7673 | 6 |
GSM780709 | Untreated after 4 days (C3_1) | 43.7692 | 21 |
GSM780719 | Untreated after 4 days (C1_2) | 44.0516 | 22 |
GSM780720 | Untreated after 4 days (C2_2) | 41.5331 | 11 |
GSM780721 | Untreated after 4 days (C3_2) | 46.9184 | 36 |
GSM780710 | Trastuzumab treated after 4 days (T1_1) | 41.7328 | 12 |
GSM780711 | Trastuzumab treated after 4 days (T2_1) | 38.5868 | 3 |
GSM780712 | Trastuzumab treated after 4 days (T3_1) | 39.9681 | 6 |
GSM780722 | Trastuzumab treated after 4 days (T1_2) | 43.1388 | 18 |
GSM780723 | Trastuzumab treated after 4 days (T2_2) | 36.6828 | 1 |
GSM780724 | Trastuzumab treated after 4 days (T3_2) | 41.3305 | 11 |
GSM780713 | Pertuzumab treated after 4 days (P1_1) | 39.3785 | 5 |
GSM780714 | Pertuzumab treated after 4 days (P2_1) | 45.2843 | 29 |
GSM780715 | Pertuzumab treated after 4 days (P3_1) | 40.8278 | 9 |
GSM780725 | Pertuzumab treated after 4 days (P1_2) | 41.0515 | 10 |
GSM780726 | Pertuzumab treated after 4 days (P2_2) | 46.3243 | 34 |
GSM780727 | Pertuzumab treated after 4 days (P3_2) | 44.7747 | 26 |
GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 42.1866 | 14 |
GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 47.8092 | 40 |
GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 40.4271 | 8 |
GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 42.4777 | 15 |
GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 41.5488 | 11 |